These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15568275

  • 1. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Whelan MA.
    Neurology; 2004 Nov 23; 63(10):1985-6; author reply 1985-6. PubMed ID: 15568275
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society.
    Whelan MA, Delgado MR.
    Neurology; 2010 Aug 17; 75(7):669. PubMed ID: 20713958
    [No Abstract] [Full Text] [Related]

  • 4. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Graf WD, Le Pichon JB, Bittel DC, Abdelmoity AT, Yu S.
    Neurology; 2010 Mar 30; 74(13):1080-1; author reply 1081. PubMed ID: 20350984
    [No Abstract] [Full Text] [Related]

  • 5. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Whelan MA.
    Neurology; 2010 Mar 30; 74(13):1079; author reply 1079. PubMed ID: 20350983
    [No Abstract] [Full Text] [Related]

  • 6. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the quality standards subcommittee of the American Academy Of Neurology and the Practice Committee Of The Child Neurology Society.
    Braillon A.
    Neurology; 2010 Mar 30; 74(13):1079-80; author reply 1080. PubMed ID: 20350982
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Practice parameter: evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society.
    Freeman JH.
    Neurology; 2001 Feb 27; 56(4):574. PubMed ID: 11261423
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Re: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Stricker RB, Johnson L.
    Neurology; 2008 May 06; 70(19):1719; author reply 1719-20. PubMed ID: 18458234
    [No Abstract] [Full Text] [Related]

  • 11. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C, Quality Standards Subcommittee of the American Academy of Neurology, Practice Committee of the Child Neurology Society.
    Neurology; 2005 Jan 11; 64(1):13-20. PubMed ID: 15642897
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence-based guideline update: Determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Shewmon DA, Sylmar CA, Verheijde JL, Rady MY.
    Neurology; 2011 Jan 18; 76(3):308; author reply 308-9. PubMed ID: 21302378
    [No Abstract] [Full Text] [Related]

  • 14. Evidence-based guideline update: Determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Machado C, Pérez-Nellar J, Estevez M, Gonzalez E.
    Neurology; 2011 Jan 18; 76(3):307; author reply 308-9. PubMed ID: 21242502
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Montgomery EB.
    Neurology; 2006 Dec 26; 67(12):2266; author reply 2266. PubMed ID: 17190966
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence-based guideline update: Determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Jeret JS.
    Neurology; 2011 Jan 18; 76(3):307-8; author reply 308-9. PubMed ID: 21302426
    [No Abstract] [Full Text] [Related]

  • 19. Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Polman CH, Deisenhammer F, Giovannoni G, Killestein J, Schellekens H.
    Neurology; 2007 Oct 09; 69(15):1553-4; author reply 1555. PubMed ID: 17923619
    [No Abstract] [Full Text] [Related]

  • 20. Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Pachner AR.
    Neurology; 2007 Oct 09; 69(15):1555; author reply 1565. PubMed ID: 17923620
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.